Illumina (San Diego, United States) sells TruSight Oncology 500/500 ctDNA RUO panel investigating 523 genes in tumor specimen or ctDNA (Wei et al., 2022) covering all glioma marker SNPs including p-TERT DNA sequence alterations (Kang et al., 2022). Here, TERT is linked to central nervous system cancer.